Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2016 Aug 30;15(9):660. doi: 10.1038/nrd.2016.178

Erratum: Oncolytic viruses: a new class of immunotherapy drugs

Howard L Kaufman, Frederick J Kohlhapp, Andrew Zloza
PMCID: PMC7608450  PMID: 30907381

Nature Reviews Drug Discovery 14, 642–662 (2015)

The following footnote has been added to Table 1: Although some adeno- and herpes viruses have the potential for nuclear integration, most oncolytic viruses under clinical development do not integrate into the nucleus.

Footnotes

The online version of the original article can be found at 10.1038/nrd4663


Articles from Nature Reviews. Drug Discovery are provided here courtesy of Nature Publishing Group

RESOURCES